CRC
NTUS

Curi RMB Capital’s Natus Medical Inc NTUS Stock Holding History

Curi RMB Capital’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-23,000
Closed -$858K – 782
2017
Q2 		$858K Buy
+23,000
New +$831K 0.02% 465

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

Curi RMB Capital's NTUS Position: Q3 2017 in Review

Curi RMB Capital sold out of Natus Medical Inc (NTUS) in Q3 2017, closing a stake of 23,000 shares — an estimated $858K sold.

Curi RMB Capital first reported a position in NTUS in Q2 2017 and held it in 1 quarter. The position peaked at $858K in Q2 2017. 198 funds tracked by Wall St. Rank hold NTUS as of Q3 2017.

  • Curi RMB Capital reported no remaining Natus Medical Inc position as of Q3 2017 after selling out during the quarter.
  • Curi RMB Capital sold 23,000 Natus Medical Inc shares in Q3 2017, an estimated $858K.
  • Curi RMB Capital first reported a position in Natus Medical Inc in Q2 2017 and held it in 1 quarter.
  • Curi RMB Capital's Natus Medical Inc position peaked at $858K in Q2 2017.
  • 198 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2017.

Based on Curi RMB Capital's 13F filing for Q3 2017, filed 14 Nov 2017.